Management of Isolated Diastolic Hypotension in Elderly Patients with Uncontrolled Systolic Hypertension

Introduction to Management

The European Society of Cardiology recommends reducing or discontinuing beta-blockers like atenolol first, as they contribute significantly to low diastolic blood pressure and are not first-line agents for uncomplicated hypertension in elderly patients, while maintaining olmesartan to control elevated systolic readings 1, 2

Beta-blockers like atenolol are not recommended as first-line therapy for uncomplicated hypertension in elderly patients and should only be used when there are compelling indications, according to the European Heart Journal 1, 2
Discontinue atenolol completely rather than tapering, as the low dose carries minimal risk in the absence of coronary disease or heart failure, as suggested by the European Heart Journal 2
Continue olmesartan as ARBs are recommended first-line agents for hypertension management and provide 24-hour blood pressure control, according to the European Heart Journal 1, 2
Monitor blood pressure both sitting and standing to assess for orthostatic hypotension, which is critical in elderly patients, as recommended by the European Heart Journal 1, 4, 5

The European Society of Cardiology recommends a target systolic blood pressure of 130-139 mmHg for elderly patients aged ≥65 years 1
Accept diastolic blood pressure of 60-79 mmHg as appropriate, avoiding aggressive lowering below 60 mmHg given the uncertain benefit-risk ratio, according to the European Heart Journal 1, 3

Check blood pressure in both sitting and standing positions at each visit to detect orthostatic hypotension, as recommended by the European Heart Journal 1, 4, 5
Assess for symptoms of hypoperfusion including dizziness, lightheadedness, syncope, falls, fatigue, or cognitive changes, according to the European Heart Journal 1, 5
Monitor renal function and electrolytes if adding a diuretic, checking within 2-4 weeks of initiation, as suggested by Praxis Medical Insights 5, 6
Achieve target blood pressure within 3 months of treatment modification, according to the European Heart Journal 1, 7
Initiate dose changes gradually with lower starting doses and slower titration compared to younger patients, as elderly patients have increased susceptibility to adverse effects, as recommended by the European Heart Journal 4
Simplify medication regimens using once-daily dosing and single-pill combinations when possible to improve adherence, according to the European Heart Journal 1, 2, 5
Continue lifelong treatment even beyond age 85 if well tolerated, as discontinuation increases cardiovascular risk, as recommended by the European Heart Journal 1, 5
Individualize based on frailty status, with more lenient targets for patients with moderate-to-severe frailty or limited life expectancy (<3 years), according to the European Heart Journal 1, 5